Registration Certificate No. :

Anhui InstrumentRegistration Licence 20192090177

Product Description:

By irradiating the nasal cavity andacupoints with a wavelength of 630nm red light, it activates blood cells,improves blood flow and enhances local blood circulation, which can effectivelytreat rhinitis. The product has completed clinical trials of allergic rhinitisin three tertiary medical institutions in April 2019, with an effective rate of79.1%, which has acceptable clinical effectiveness and safety, and meets the requirementsof clinical application.

Product Features Description:

1.The nasal lesions of rhinitis were irradiated directlyby a low energy cold narrow-band laser with a wavelength of 630 nm, which isthe most narrow spectrum and the most penetrating medical laser at present.

2.Rhinitis phototherapy is very concentrated and doesnot affect other parts of the body.

3.The 630 nm low-energy narrow-band cold laser canpenetrate into the subcutaneous tissue for 5 mm, providing the energy needed toactivate cells and deeply activate the activity of the lesion tissue.

4.Improve the natural resistance of nasal tissue andprevent the recurrence of rhinitis.

5. It is a noninvasive, no side effects, small size,easy to carry and significant effect of biological therapeutic instrument.

Clinically applicable departments(surgery) :

Patients with rhinitis (patients with persistent oldrhinitis, patients with recurrent refractory rhinitis, patients with recurrentrhinitis after surgery, patients with ineffective oral drugs and rhinitis,allergic and other types of rhinitis).

Product Specification: